This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874839 ISLET.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874839 ISLET.

A European project innovating advanced cell-therapy for Diabetes

Improving the lives of people with diabetes

World renowned
Diabetes expertise

Discover
ISLET

ISLET is spearheaded by a unique scientific team that share an ambitious common goal: to pioneer a new advanced cell therapy for Type 1 Diabetes. Our team combines the wealth of expertise, facilities and knowledge of seven institutions to allow key findings to be translated into a therapy. As a team ISLET has a unique power to improve the lives of people living with diabetes, not just through therapy, but through advanced public engagement and communication. Meet our people and explore our goal.

read more

Living with
Diabetes

With 463 million people worldwide living with diabetes there is a large demand for new treatments. Diabetes is a chronic disease with no cure. It occurs when the pancreas is no longer able to make insulin, or when the body cannot make good use of the insulin it produces. Take a glance into the life of someone with the condition.

read more

Advanced
Therapies

An advanced therapy uses new medical products that involve gene therapy, cell therapy, and tissue engineering. This is a fast evolving area with ground-breaking potential for the future treatment of a wide-array of diseases and injuries. Delve into the science of these approaches.

read more

Latest news from ISLET

see all news
ISLET project kicks off

ISLET project kicks off

Meeting in Copenhagen on 5th and 6th March 2020, the ISLET team gathered to mark the start of the 8 ...

read more